Vitrolife’s share capital and number of shares on November 28, 2014

As per November 28, 2014, the total number of shares in Vitrolife AB (publ)
amounts to 21,710,115, of which Vitrolife itself holds 0 shares. The share
capital amounts to SEK 22,144,317.30.
At the beginning of the month the total number of shares in the company amounted
to 19,830,936, of which Vitrolife itself held 0 shares. The share capital
amounted to SEK 20,227,554.72.

The increase in the number of shares by 1,879,179 during the month of November
is due to the non-cash issue of shares with regards to the acquisition of
Unisense FertiliTech A/S.

November 28, 2014
Gothenburg
VITROLIFE AB (publ)
Thomas Axelsson, CEO
Queries should be addressed to:

Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14

Vitrolife is required to publish the information in this press release in
accordance with the Swedish Securities Market Act and/or the Financial
Instruments Trading Act. The information was submitted for publication
on November 28, 2014 at 2:30 p.m.

This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.
________________________________________________________________________________
_ 
________________________________

Vitrolife is an international medical device Group. The Fertility product area
develops, produces and markets medical devices for assisted reproduction. Work
is also carried out to enable the use and handling of stem cells for therapeutic
purposes.

Vitrolife has about 320 employees and the company’s products are sold in about
110 markets. The company is headquartered in Gothenburg, Sweden, and there are
also offices in USA, Australia, France, Italy, United Kingdom, China, Japan,
Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX Stockholm,
Small Cap.

________________________________________________________________________________
_ 
________________________________

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity
number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail:
info@vitrolife.com. Website: www.vitrolife.com/